The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Enrollment
50
$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment
$50 incentive paid to participant for completion of flu shot within 2 months of enrollment
$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment
Tulane University School of Medicine
New Orleans, Louisiana, United States
Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms
Completion of colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test as documented in electronic health record within two months of study enrollment
Time frame: Two months
Difference in Percent of Participants Completing COVID-19 Shot Between Study Arms
Completion of COVID-19 shot as documented in electronic health record within two months of study enrollment
Time frame: Two months
Difference in Percent of Participants Completing Flu Shot Between Study Arms
Completion of flu shot as documented in electronic health record within two months of study enrollment
Time frame: Two months
Difference in Percent of Participants Completing at Least One of the Following Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot
Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, \*OR\* flu shot as documented in electronic health record within two months of study enrollment
Time frame: Two months
Difference in Percent of Participants Completing All Three Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot
Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, \*AND\* flu shot as documented in electronic health record within two months of study enrollment
Time frame: Two months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.